Global clinical trial reveals safest, most effective antibiotics for golden staph bloodstream infections
A global clinical trial has identified the most effective and safe antibiotic treatments for golden staph bloodstream infections. The research aims to improve patient outcomes by standardizing treatment protocols for this serious condition.
Why it matters
Antibiotic resistance is a major global health crisis, and identifying effective treatments for staph infections is vital for hospital safety.
here About us Strategy Our partners Our Team Fundraising partners BorneHMRI Hunter Children’s Research Foundation Hunter Transplant Research Foundation Governance Contact us Impact Research Research programs Researchers Research services Hunter New England Clinical Trials Clinical Trials Support Unit Clinical Trials Facility Clinical Trials Coordinating Centre Biostatistics Data Management Health Informatics Grants Development Health economics Histology Imaging centre Impact and evaluation Research Funding Opportunities Get involved Support us Donate Regular giving Corporate giving Gift in Will Donate in memory Fundraise Philanthropic giving Volunteer Partner with us Participate in research Events HMRI Health Pulse HMRI Dementia Exchange News and stories Discover Hub Subscribe to eNews Media Centre Searcher Magazine About us Strategy Our partners Our Team Fundraising partners BorneHMRI Hunter Children’s Research Foundation Hunter Transplant Research Foundation Governance Contact us Impact Research Research programs Researchers Research services Hunter New England Clinical Trials Clinical Trials Support Unit Clinical Trials Facility Clinical Trials Coordinating Centre Biostatistics Data Management Health Informatics Grants Development Health economics Histology Imaging centre Impact and evaluation Research Funding Opportunities Get involved Support us Donate Regular giving Corporate giving Gift in Will Donate in memory Fundraise Philanthropic giving Volunteer Partner with us Participate in research Events HMRI Health Pulse HMRI Dementia Exchange News and stories Discover Hub Subscribe to eNews Media Centre Searcher Magazine Donate Partner on a Clinical Trial About us Strategy Our partners Our Team Fundraising partners BorneHMRI Hunter Children’s Research Foundation Hunter Transplant Research Foundation Governance Contact us Impact Research Research programs Researchers Research services Hunter New England Clinical Trials Clinical Trials Support Unit Clinical Trials Facility Clinical Trials Coordinating Centre Biostatistics Data Management Health Informatics Grants Development Health economics Histology Imaging centre Impact and evaluation Research Funding Opportunities Get involved Support us Donate Regular giving Corporate giving Gift in Will Donate in memory Fundraise Philanthropic giving Volunteer Partner with us Participate in research Events HMRI Health Pulse HMRI Dementia Exchange News and stories Discover Hub Subscribe to eNews Media Centre Searcher Magazine About us Strategy Our partners Our Team Fundraising partners BorneHMRI Hunter Children’s Research Foundation Hunter Transplant Research Foundation Governance Contact us Impact Research Research programs Researchers Research services Hunter New England Clinical Trials Clinical Trials Support Unit Clinical Trials Facility Clinical Trials Coordinating Centre Biostatistics Data Management Health Informatics Grants Development Health economics Histology Imaging centre Impact and evaluation Research Funding Opportunities Get involved Support us Donate Regular giving Corporate giving Gift in Will Donate in memory Fundraise Philanthropic giving Volunteer Partner with us Participate in research Events HMRI Health Pulse HMRI Dementia Exchange News and stories Discover Hub Subscribe to eNews Media Centre Searcher Magazine / Home / Global clinical trial reveals safest, most effective antibiotics for golden staph bloodstream infections Home / Research / Infection Research / Global clinical trial reveals safest, most effective antibiotics for golden staph bloodstream infections Global clinical trial reveals safest, most effective antibiotics for golden staph bloodstream infections Date Published: June 18, 2026 Treatment practice is set to change: The SNAP Trial found that flucloxacillin should no longer be the default treatment for many golden staph bloodstream infections, with cefazolin and benzylpenicillin proving equally effective and safer. Better outcomes for patients: Both alternative antibiotics were linked to less kidney damage, with cefazolin and benzylpenicillin also showing lower mortality rates than flucloxacillin. Global impact: Led by the University of Newcastle and Peter Doherty Institute for Infection and Immunity , the world s largest golden staph infection trial could reshape treatment guidelines internationally. A landmark international clinical trial has identified the optimal antibiotics for golden staph bloodstream infections, a breakthrough that is set to reshape treatment for the life-threatening condition. The SNAP Trial found that the standard antibiotic, flucloxacillin, should no longer be the drug of choice to treat the infection, revealing that cefazolin and benzylpenicillin offer safer and equally effective alternatives to patients.
The article reports on medical research findings in a factual, objective manner.
Get smarter about the news
Sign up free for a feed built around what you actually care about, Dive Deeper research on any story, and the full text of every article.
Create free accountAlready have an account? Sign in